The next 12-24 months should be interesting in the biotech and pharmaceutical industries. We have the large pharmaceutical companies holding onto a lot of cash. Yet, large pharma is very cognizant of the number of high profile drugs coming off U.S. patent soon....
In honor of today being National Stem Cell Awareness Day, Gov. Jim Doyle reaffirmed Wisconsin’s role as a major force in stem cell research. Doyle spokesperson Lee Sensenbrenner said Doyle has always been an advocate of stem cell research. “Starting with his first campaign, the governor all...
California's stem cell agency has teamed with Maryland's stem cell organization in the first interstate agreement designed to speed research progress through collaboration among scientists. The agreement, announced Tuesday by leaders of the California Institute for Regenerative Medicine and the Maryland Technology Development Corp., will encourage...
In the world of biotech, the assumption is that the two poles of greatest and best activity center around San Francisco on the West Coast and Boston on the East Coast. This assumption is based on the historic role each city has played over...
BioForward has selected the six Wisconsin biotechnology companies for the first Emerging Company Showcase. The showcase is part of the Biotechnology Vision Summit 2009, hosted by BioForward. The companies were chosen because they have transitioned successfully out of the laboratory, with good proof of concept...
In a Proclamation released by the Office of the Governor, Governor Doyle recounts the leading role that the State of Wisconsin has played in the field of stem cell research, calling it “a field that represents not just an exponential advance in the sum total...
Stemina Biomarker Discovery and California Stem Cell collaborate to validate effectiveness of human embryonic stem cell-derived cardiomyocyte progenitors for use in predictive toxicology. They've concluded that the study using CSC’s 96-well CardioPlate containing high purity human embryonic stem cell (hESC)-derived cardiomyocyte progenitor cells, has demonstrated...
How biotechnology companies can thrive in the difficult economic conditions and prepare themselves for the unprecedented opportunity of the coming decade is the theme of the Biotechnology Vision Summit 2009. The summit will explore how companies can meet the challenges of the current economy and...
From one perspective, the life sciences industry — the biotechnology companies that develop drugs and treatments to combat disease and the biomedical firms that create medical devices — is a picture of expanding horizons and confidence, The New York Times’s James Flanigan writes. Young companies are...
Semba Biosciences Inc. has received a $250,000 Technology Venture Fund loan from the Wisconsin Department of Commerce for equipment and working capital to expand its capabilities into additional product lines and international distribution. ...